期刊
AUTOPHAGY
卷 7, 期 12, 页码 1424-1433出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/auto.7.12.18027
关键词
Atg13; autophagy; FIP200; Ulk1; Ulk2
类别
资金
- Deutsche Forschungsgemeinschaft [SFB 773, GRK 1302]
- Interdisciplinary Center of Clinical Research, Faculty of Medicine, Tiibingen [Nachwuchsgruppe 1866-0-0]
- UK Medical Research Council
- AstraZeneca
- Boehringer-Ingelheim
- GlaxoSmithKline
- Merck-Serono
- Pfizer
Under normal growth conditions the mammalian target of rapamycin complex 1 (mTORC1) negatively regulates the central autophagy regulator complex consisting of Unc-51-like kinases 1/2 (Ulk1/2), focal adhesion kinase family-interacting protein of 200 kDa (FIP200) and Atg13. Upon starvation, mTORC1-mediated repression of this complex is released, which then leads to Ulk1/2 activation. In this scenario, Atg13 has been proposed as an adaptor mediating the interaction between Ulk1/2 and FIP200 and enhancing Ulk1/2 kinase activity. Using Atg13-deficient cells, we demonstrate that Atg13 is indispensable for autophagy induction. We further show that Atg13 function strictly depends on FIP200 binding. In contrast, the simultaneous knockout of Ulk1 and Ulk2 did not have a similar effect on autophagy induction. Accordingly, the Ulk1-dependent phosphorylation sites we identified in Atg13 are expendable for this process. This suggests that Atg13 has an additional function independent of Ulk1/2 and that Atg13 and FIP200 act in concert during autophagy induction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据